Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11542278 Heteroaromatic macrocyclic ether chemotherapeutic agents

Patent 11542278 was granted and assigned to Nuvalent on January, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

January 3, 2023

Patent Application Number

17514877

Date Filed

October 29, 2021

Patent Citations

US Patent 11008323 Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteric modulators of group II metabotropic glutamate receptors

US Patent 10593889 Compound and organic electroluminescence device

US Patent 10147887 Compound and organic light-emitting device including the same

US Patent 10189803 Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions

US Patent 10208068 Macrocycles as factor XIa inhibitors

US Patent 10243153 Material for organic electroluminescence device and organic electroluminescence device

US Patent 10335392 Cyclic compounds useful as modulators of TNF α

Patent Citations Received

0

0

Patent Primary Examiner

Douglas M Willis

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11542278 Heteroaromatic macrocyclic ether chemotherapeutic agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool